NCT02317354View on ClinicalTrials.gov

People s Expectations When Enrolling in a Phase I/II RS1 Ocular Gene Transfer Clinical Trial

CompletedOBSERVATIONAL
Enrollment

13

Participants

Timeline

Start Date

December 13, 2014

Primary Completion Date

November 20, 2017

Study Completion Date

November 20, 2017

Conditions
RetinoschisisX-Linked
Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Eye Institute (NEI)

NIH

NCT02317354 - People s Expectations When Enrolling in a Phase I/II RS1 Ocular Gene Transfer Clinical Trial | Biotech Hunter | Biotech Hunter